Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 10... by Monk, Bradley J, Colombo, Nicoletta, Oza, Amit M, Fujiwara, Keiichi, Birrer, Michael J, Randall, Leslie, Poddubskaya, Elena V, Scambia, Giovanni, Shparyk, Yaroslav V, Lim, Myong Cheol, Bhoola, Snehalkumar M, Sohn, Joohyuk, Yonemori, Kan, Stewart, Ross A, Zhang, Xiaoxi, Perkins Smith, Julia, Linn, Carlos, Ledermann, Jonathan A

Get full text

Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2− advanced breast... by Finn, Richard S., Boer, Katalin, Bondarenko, Igor, Patel, Ravindranath, Pinter, Tamas, Schmidt, Marcus, Shparyk, Yaroslav V., Thummala, Anu, Voitko, Nataliia, Bananis, Eustratios, McRoy, Lynn, Wilner, Keith, Huang, Xin, Kim, Sindy, Slamon, Dennis J., Ettl, Johannes

Get full text

Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial by Pivot, Xavier, Cortés, Javier, Lüftner, Diana, Lyman, Gary H, Curigliano, Giuseppe, Bondarenko, Igor M, Ahn, Jin-Hee, Im, Seock-Ah, Litwiniuk, Maria, Shparyk, Yaroslav V, Ho, Gwo Fuang, Kislov, Nikolay V, Wojtukiewicz, Marek, Sarosiek, Tomasz, Chae, Yee Soo, Ahn, Jin Seok, Jang, Hyerin, Kim, Sujung, Lee, Jiwon, Yoon, YeChan

Get full text

Abstract P2-13-04: Final survival analysis of a phase 3 study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in HER2-positive early or locally advanced breast can... by Pivot, Xavier, Pegram, Mark D, Cortes, Javier, Lüftner, Diana, Lyman, Gary H, Curigliano, Giuseppe, Bondarenko, Igor M, Dvorkin, Mikhail, Ahn, Jin Hee, Im, Seock-Ah, Litwiniuk, Maria, Shparyk, Yaroslav V, Ho, Gwo Fuang, Kislov, Nikolay V, Wojtukiewicz, Marek, Sarosiek, Tomasz, Chae, Yee Soo, Ahn, Jin Seok, Jang, Hyerin, Kim, Sujung, Lee, Jiwon, Lee, Soo Young, Yoon, Ye Chan

Get full text

Abstract CT101: Final results of a randomized Phase II study of PD 0332991, a cyclin-dependent kinase (CDK)-4/6 inhibitor, in combination with letrozole vs letrozole alone for firs... by Finn, Richard S., Crown, John P., Lang, Istvan, Boer, Katalin, Bondarenko, Igor M., Kulyk, Sergey O., Ettl, Johannes, Patel, Ravindranath, Pinter, Tamas, Schmidt, Marcus, Shparyk, Yaroslav V., Thummala, Anu R., Voytko, Nataliya L., Huang, Xin, Kim, Sindy T., Randolph, Sophia S., Slamon, Dennis J.

Get full text